This inventor holds 1 USPTO granted patent. Top assignee: Dojindo Laboratories. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Ryusuke Tsunoda: Innovator in Coronary Blood Vessel Dilation
Introduction
Ryusuke Tsunoda is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that aid in coronary blood vessel dilation. His innovative work has the potential to improve cardiovascular health and patient outcomes.
Latest Patents
Tsunoda holds a patent for "Imidazolinoxyl derivatives," which presents novel compounds exhibiting a long-acting coronary blood vessel dilating action. The patent describes a general formula for these imidazolinoxyl derivatives, with a specific example of a compound where R is COOH. The compounds can be directly administered after dilution with a phosphate buffer, resulting in significant and long-lasting relaxation of blood vessels, despite their rapid inactivation and excretion in blood flow.
Career Highlights
Ryusuke Tsunoda has dedicated his career to research and development in the pharmaceutical industry. He is currently associated with Dojindo Laboratories, where he continues to innovate and contribute to advancements in medicinal chemistry. His work is characterized by a focus on creating effective therapeutic agents that address critical health issues.
Collaborations
Tsunoda has collaborated with esteemed colleagues, including Takaaki Akaike and Ken Okumura. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to impactful innovations in the field.
Conclusion
Ryusuke Tsunoda's contributions to the field of coronary blood vessel dilation through his patented imidazolinoxyl derivatives exemplify his commitment to advancing medical science. His work at Dojindo Laboratories and collaborations with fellow researchers highlight the importance of teamwork in driving innovation.